查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1822386

二氧化碳疗法市场预测至 2032 年：按产品类型、疗法类型、气体类型、设备类型、应用、最终用户和地区进行的全球分析

Carboxy Therapy Market Forecasts to 2032 - Global Analysis By Product Type (Tabletop Devices, Portable Devices, and Other Product Types), Treatment Type, Gas Type, Device Type, Application, End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球二氧化碳疗法市场预计在 2025 年达到 5,006 万美元，到 2032 年将达到 1.245 亿美元，预测期内复合年增长率为 13.9%。

二氧化碳疗法是一种非手术美容疗法，透过皮下注射定量的二氧化碳气体来实现。该疗法透过促进血液循环、增加氧气输送和刺激胶原蛋白生成来发挥作用。它通常用于减少橘皮组织、疤痕、妊娠纹和顽固脂肪，同时改善皮肤紧緻度和纹理。透过自然的组织修復和再生，二氧化碳疗法为改善皮肤和塑造体形提供了一个有效、微创的方案。

整容手术正在兴起，国际美容整形整形外科学会 (ISAPS) 最近发布的统计数据显示，2021 年整容手术总体增加了 19.3%。

非侵入性美容手术的需求不断增加

非侵入性美容疗法日益偏好，这极大地推动了二氧化碳疗法市场的发展。消费者越来越倾向于选择那些效果显着、恢復期短且风险低的疗法。设备精度和气体输送系统的进步正在提高治疗效果和患者舒适度。社群媒体和美妆达人的崛起，正在推动人们对活肤和减少脂肪团治疗的认知和需求。诊所正在将二氧化碳疗法融入其更广泛的抗衰老和塑身产品组合中，并藉助数位影像和个人化治疗方案。随着美容医学转向预防和维护型护理，像二氧化碳疗法这样的非侵入性治疗方法正成为主流。

不同的监管政策和安全问题

核准流程差异很大，一些国家实施了严格的临床检验和设备认证标准。围绕气体纯度、剂量控制和通讯协定的安全问题正在推动监管力度的加强。製造商必须应对复杂的合规环境，包括 CE 标誌、FDA 批准和 ISO 标准。智慧感测器和自动流量稳压器的整合有助于弥补安全漏洞，但也增加了监管复杂性。规模较小的公司经常面临延误和成本负担，这限制了创新，并减缓了产品在关键市场的推出。

美容诊所的兴起

提供先进皮肤护理的精品医疗水疗中心和皮肤科连锁店正在城区和二线城市蓬勃发展。诊所正在投资紧凑型多功能设备，以支持二氧化碳疗法以及微针和射频等其他疗法。在新兴市场，专利权模式和承包解决方案的采用正在加速设备的普及。数位行销和线上预约平台正在扩大患者就诊管道，并增加治疗量。在竞争日益激烈的背景下，诊所正透过技术升级、个人化护理和配套服务来脱颖而出。

可能造成负面宣传和消费者不信任

负面体验在社群媒体上被放大，会削弱消费者的信任，并减少新用户的使用。医疗服务提供者缺乏标准化的培训和认证，导致流程差异化。监管机构越来越多地要求提供者认证和设备可追溯性，以减少医疗失误。企业正在透过进行病患教育宣传活动和透明的安全资料来恢復信任。然而，如果没有强有力的品质保证和治疗后支持，市场仍然容易受到质疑和抵制。

COVID-19的影响

疫情扰乱了美容医疗服务的提供，封锁措施导致选择性治疗暂停，门诊就诊量减少。供应链中断影响了设备的可用性和维护週期，减缓了新设备的安装。然而，这场危机加速了数位化，诊所开始采用虚拟咨询和远端皮肤评估。疫情过后，随着消费者更加重视自我护理和改善外貌，需求开始復苏。医疗服务的分散化和向家用设备的转变正在重塑美容治疗的交付模式。

预计桌上型设备市场在预测期内将占据最大份额

桌上型设备凭藉其多功能性和临床级性能，预计将在预测期内占据最大的市场份额。这些系统提供精确的气流控制、可客製化的治疗通讯协定，并相容于多种探头。诊所青睐桌上型设备，因为它们耐用、符合人体工学设计，并且能够处理大量患者。触控萤幕介面和即时监控的整合提高了易用性和治疗精度。製造商正专注于模组化升级和软体主导的增强功能，以延长设备的生命週期。随着对专业级设备的需求不断增长，桌上型系统仍然是美容基础设施的支柱。

预测期内，Medspa 细分市场将以最高复合年增长率成长

在健康与美容护理混合模式的推动下，医疗水疗中心 (Medspa) 预计将在预测期内实现最高成长率。这些机构正迅速采用二氧化碳疗法作为整体活肤和抗衰老疗法的一部分。非侵入性治疗和最短的恢復时间与医疗水疗中心的客户群相契合。人工智慧皮肤分析与个人化治疗方案的结合正在推动该疗法的普及。医疗水疗中心正在利用影响力行销和订阅式服务模式来留住客户并扩大业务规模。随着消费者需求转向体验式和结果导向护理，医疗水疗中心正逐渐成为重要的成长中心。

比最大的地区

在预测期内，受可支配收入成长和美容意识增强的推动，亚太地区预计将占据最大的市场份额。韩国、中国和印度等国家正经历美容诊所和皮肤科中心的快速扩张。政府推动医疗旅游和设备在地化的倡议正在刺激市场渗透。区域参与者正在与全球原始设备製造商合作，推出经济高效且符合当地文化的解决方案。美白、抗衰老和减少疤痕疗法的流行推动了二氧化碳疗法的广泛应用。技术进步和积极的行销策略正在巩固亚太地区在美容创新领域的领导地位。

复合年增长率最高的地区：

预计北美将在预测期内呈现最高的复合年增长率，这得益于强劲的研发实力和早期技术应用。美国和加拿大越来越多地采用整合分析和云端基础治疗追踪功能的智慧美容设备。监管机构正在简化创新非侵入性治疗方法的核准途径，加速其商业化进程。诊所正在投资培训、认证和配套服务，以改善患者的治疗效果。注重健康的消费者的崛起和对个人化护肤的需求正在推动治疗数量的成长。凭藉着日趋成熟的数位平台和影响力生态系统，北美将持续引领美容市场的发展。

免费客製化服务：

此报告的订阅者可以使用以下免费自订选项之一：

  • 公司简介
    • 对最多三家其他市场公司进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球二氧化碳疗法市场（依产品类型）

  • 桌面设备
  • 行动装置
  • 其他产品类型

6. 全球二氧化碳疗法市场（依治疗类型）

  • 医学二氧化碳疗法
  • 美容二氧化碳疗法

7. 全球二氧化碳疗法市场（依气体种类）

  • 二氧化碳
  • 氧

8. 全球二氧化碳疗法市场（以设备类型）

  • 独立设备
  • 手持装置

9. 全球二氧化碳疗法市场（按应用）

  • 拉伸
  • 去除橘皮组织
  • 脱髮症
  • 疼痛管理
  • 银屑病
  • 活肤
  • 黑眼圈
  • 心血管和糖尿病应用
  • 再生医学
  • 其他用途

第 10 章全球二氧化碳疗法市场（按最终用户）

  • 医院
  • 美容诊所
  • 医疗水疗中心
  • 水疗和沙龙
  • 美容中心
  • 其他最终用户

第 11 章全球二氧化碳疗法市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十二章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十三章：企业概况

  • Fosun Pharmaceutical Co., Ltd.
  • MBE Medical Division
  • Merz Pharma GmbH & Co. KGaA
  • Medipark Co., Ltd.
  • Allergan plc
  • Italcarbo Srl
  • Alvi Prague
  • Mezopharma
  • JONTE
  • Kastner-Praxisbedarf
  • Anti-Aging Medical Systems
  • Carbossiterapia Italiana
  • DTA Medical
  • Beijing Jontelaser Technologies Co., Ltd.
  • Cosmo Pro Ltd
Product Code: SMRC31140

According to Stratistics MRC, the Global Carboxy Therapy Market is accounted for $50.06 million in 2025 and is expected to reach $124.50 million by 2032 growing at a CAGR of 13.9% during the forecast period. Carboxy Therapy is a non-surgical aesthetic procedure where controlled amounts of carbon dioxide gas are injected under the skin. The treatment works by boosting blood circulation, increasing oxygen delivery, and stimulating collagen formation. Commonly applied to minimize cellulite, scars, stretch marks, and stubborn fat, it enhances skin firmness and texture. Through natural tissue repair and rejuvenation, Carboxy Therapy provides an effective, minimally invasive option for skin improvement and body contouring.

According to recent statistics published by the International Society of Aesthetic Plastic Surgery (ISAPS), aesthetic and cosmetic procedures have seen a surge with an overall increase of 19.3% of plastic surgeries performed in 2021.

Market Dynamics:

Driver:

Increasing demand for non-invasive aesthetic procedures

The growing preference for non-invasive cosmetic treatments is significantly propelling the carboxy therapy market. Consumers are increasingly opting for procedures that offer visible results with minimal downtime and reduced risk. Advancements in device precision and gas delivery systems are enhancing treatment efficacy and patient comfort. The rise of social media and beauty influencers is amplifying awareness and demand for skin rejuvenation and cellulite reduction therapies. Clinics are integrating carboxy therapy into broader anti-aging and body contouring portfolios, supported by digital imaging and personalized treatment planning. As aesthetic medicine shifts toward preventive and maintenance-based care, non-invasive modalities like carboxy therapy are gaining mainstream traction.

Restraint:

Varying regulatory policies and safety concerns

Approval processes differ widely, with some countries enforcing stringent clinical validation and device certification standards. Safety concerns around gas purity, dosage control, and procedural protocols are prompting tighter oversight. Manufacturers must navigate complex compliance landscapes, including CE marking, FDA clearance, and ISO standards. The integration of smart sensors and automated flow regulators is helping address safety gaps but adds to regulatory complexity. Smaller players often face delays and cost burdens, limiting innovation and slowing product rollout in key markets.

Opportunity:

Increasing number of aesthetic clinics

Urban centers and tier-2 cities are witnessing a surge in boutique medspas and dermatology chains offering advanced skin treatments. Clinics are investing in compact, multi-functional devices that support carboxy therapy alongside other modalities like microneedling and RF. Emerging markets are embracing franchised models and turnkey solutions, accelerating device adoption. Digital marketing and online booking platforms are expanding patient access and driving procedural volumes. As competition intensifies, clinics are differentiating through technology upgrades, personalized care, and bundled service offerings.

Threat:

Potential for negative publicity and consumer distrust

Social media amplification of negative experiences may erode consumer confidence and deter new users. Lack of standardized training and certification across providers contributes to procedural variability. Regulatory bodies are increasingly mandating practitioner accreditation and device traceability to mitigate malpractice. Companies are responding with patient education campaigns and transparent safety data to rebuild trust. However, without robust quality assurance and post-treatment support, the market remains vulnerable to skepticism and backlash.

Covid-19 Impact

The pandemic disrupted aesthetic service delivery, with lockdowns halting elective procedures and reducing clinic footfall. Supply chain interruptions affected device availability and maintenance cycles, delaying new installations. However, the crisis accelerated digital engagement, with clinics adopting virtual consultations and remote skin assessments. Demand rebounded post-pandemic as consumers prioritized self-care and appearance enhancement. The shift toward decentralized care and home-use devices is reshaping the delivery model for aesthetic treatments.

The tabletop devices segment is expected to be the largest during the forecast period

The tabletop devices segment is expected to account for the largest market share during the forecast period, due to its versatility and clinical-grade performance. These systems offer precise gas flow control, customizable treatment protocols, and compatibility with multiple applicators. Clinics prefer tabletop units for their durability, ergonomic design, and ability to handle high patient volumes. Integration of touchscreen interfaces and real-time monitoring is enhancing usability and treatment accuracy. Manufacturers are focusing on modular upgrades and software-driven enhancements to extend device lifecycle. As demand for professional-grade equipment rises, tabletop systems remain the backbone of aesthetic infrastructure.

The medspas segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the medspas segment is predicted to witness the highest growth rate, driven by their hybrid model of wellness and cosmetic care. These facilities are rapidly adopting carboxy therapy as part of holistic skin rejuvenation and anti-aging packages. The appeal of non-invasive treatments with minimal recovery time aligns well with medspa clientele. Integration of AI-based skin analysis and personalized treatment plans is boosting procedural uptake. Medspas are leveraging influencer marketing and subscription-based service models to retain customers and scale operations. As consumer demand shifts toward experiential and results-driven care, medspas are emerging as key growth hubs.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share supported by rising disposable incomes and beauty consciousness. Countries like South Korea, China, and India are witnessing rapid expansion of aesthetic clinics and dermatology centers. Government initiatives promoting medical tourism and device localization are fueling market penetration. Regional players are collaborating with global OEMs to introduce cost-effective, culturally tailored solutions. The popularity of skin whitening, anti-aging, and scar reduction treatments is driving carboxy therapy adoption. Technological advancements and aggressive marketing strategies are reinforcing Asia Pacific's leadership in aesthetic innovation.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by strong R&D and early technology adoption. The U.S. and Canada are embracing smart aesthetic devices with integrated analytics and cloud-based treatment tracking. Regulatory bodies are streamlining approval pathways for innovative non-invasive therapies, accelerating commercialization. Clinics are investing in training, certification, and bundled service offerings to enhance patient outcomes. The rise of wellness-focused consumers and demand for personalized skincare is boosting procedural volumes. As digital platforms and influencer ecosystems mature, North America continues to set the pace for aesthetic market evolution.

Key players in the market

Some of the key players profiled in the Carboxy Therapy Market include Fosun Pharmaceutical Co., Ltd., MBE Medical Division, Merz Pharma GmbH & Co. KGaA, Medipark Co., Ltd., Allergan plc, Italcarbo Srl, Alvi Prague, Mezopharma, JONTE, Kastner-Praxisbedarf, Anti-Aging Medical Systems, Carbossiterapia Italiana, DTA Medical, Beijing Jontelaser Technologies Co., Ltd., and Cosmo Pro Ltd.

Key Developments:

In July 2025, Neuco UnitedCo., Limited and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. announced the signing of an exclusive licensing agreement for the manufacturing and commercialization of AR1001 in Greater China, encompassing in Chinese mainland, Hong Kong Special Administrative Region (SAR), Macau SAR.

In April 2024, Merz Therapeutics has entered into an Asset Purchase Agreement to acquire two commercial medicines from NASDAQ-listed Acorda Therapeutics. Closing of the transaction would significantly contribute to the accelerated growth strategy of Merz Therapeutics.

Product Types Covered:

  • Tabletop Devices
  • Portable Devices
  • Other Product Types

Treatment Types Covered:

  • Medical Carboxytherapy
  • Cosmetic Carboxytherapy

Gas Types Covered:

  • Carbon Dioxide
  • Oxygen

Device Types Covered:

  • Stand-alone Devices
  • Handheld Devices

Applications Covered:

  • Stretch Marks
  • Cellulite Reduction
  • Alopecia
  • Pain Management
  • Psoriasis
  • Skin Rejuvenation
  • Dark Circles
  • Cardiovascular and Diabetic Applications
  • Regenerative Medicine
  • Other Applications

End Users Covered:

  • Hospitals
  • Aesthetic Clinics
  • Medspas
  • Spas and Salons
  • Beauty Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Carboxy Therapy Market, By Product Type

  • 5.1 Introduction
  • 5.2 Tabletop Devices
  • 5.3 Portable Devices
  • 5.4 Other Product Types

6 Global Carboxy Therapy Market, By Treatment Type

  • 6.1 Introduction
  • 6.2 Medical Carboxytherapy
  • 6.3 Cosmetic Carboxytherapy

7 Global Carboxy Therapy Market, By Gas Type

  • 7.1 Introduction
  • 7.2 Carbon Dioxide
  • 7.3 Oxygen

8 Global Carboxy Therapy Market, By Device Type

  • 8.1 Introduction
  • 8.2 Stand-alone Devices
  • 8.3 Handheld Devices

9 Global Carboxy Therapy Market, By Application

  • 9.1 Introduction
  • 9.2 Stretch Marks
  • 9.3 Cellulite Reduction
  • 9.4 Alopecia
  • 9.5 Pain Management
  • 9.6 Psoriasis
  • 9.7 Skin Rejuvenation
  • 9.8 Dark Circles
  • 9.9 Cardiovascular and Diabetic Applications
  • 9.10 Regenerative Medicine
  • 9.11 Other Applications

10 Global Carboxy Therapy Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals
  • 10.3 Aesthetic Clinics
  • 10.4 Medspas
  • 10.5 Spas and Salons
  • 10.6 Beauty Centers
  • 10.7 Other End Users

11 Global Carboxy Therapy Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Fosun Pharmaceutical Co., Ltd.
  • 13.2 MBE Medical Division
  • 13.3 Merz Pharma GmbH & Co. KGaA
  • 13.4 Medipark Co., Ltd.
  • 13.5 Allergan plc
  • 13.6 Italcarbo Srl
  • 13.7 Alvi Prague
  • 13.8 Mezopharma
  • 13.9 JONTE
  • 13.10 Kastner-Praxisbedarf
  • 13.11 Anti-Aging Medical Systems
  • 13.12 Carbossiterapia Italiana
  • 13.13 DTA Medical
  • 13.14 Beijing Jontelaser Technologies Co., Ltd.
  • 13.15 Cosmo Pro Ltd

List of Tables

  • Table 1 Global Carboxy Therapy Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Carboxy Therapy Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Carboxy Therapy Market Outlook, By Tabletop Devices (2024-2032) ($MN)
  • Table 4 Global Carboxy Therapy Market Outlook, By Portable Devices (2024-2032) ($MN)
  • Table 5 Global Carboxy Therapy Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 6 Global Carboxy Therapy Market Outlook, By Treatment Type (2024-2032) ($MN)
  • Table 7 Global Carboxy Therapy Market Outlook, By Medical Carboxytherapy (2024-2032) ($MN)
  • Table 8 Global Carboxy Therapy Market Outlook, By Cosmetic Carboxytherapy (2024-2032) ($MN)
  • Table 9 Global Carboxy Therapy Market Outlook, By Gas Type (2024-2032) ($MN)
  • Table 10 Global Carboxy Therapy Market Outlook, By Carbon Dioxide (2024-2032) ($MN)
  • Table 11 Global Carboxy Therapy Market Outlook, By Oxygen (2024-2032) ($MN)
  • Table 12 Global Carboxy Therapy Market Outlook, By Device Type (2024-2032) ($MN)
  • Table 13 Global Carboxy Therapy Market Outlook, By Stand-alone Devices (2024-2032) ($MN)
  • Table 14 Global Carboxy Therapy Market Outlook, By Handheld Devices (2024-2032) ($MN)
  • Table 15 Global Carboxy Therapy Market Outlook, By Application (2024-2032) ($MN)
  • Table 16 Global Carboxy Therapy Market Outlook, By Stretch Marks (2024-2032) ($MN)
  • Table 17 Global Carboxy Therapy Market Outlook, By Cellulite Reduction (2024-2032) ($MN)
  • Table 18 Global Carboxy Therapy Market Outlook, By Alopecia (2024-2032) ($MN)
  • Table 19 Global Carboxy Therapy Market Outlook, By Pain Management (2024-2032) ($MN)
  • Table 20 Global Carboxy Therapy Market Outlook, By Psoriasis (2024-2032) ($MN)
  • Table 21 Global Carboxy Therapy Market Outlook, By Skin Rejuvenation (2024-2032) ($MN)
  • Table 22 Global Carboxy Therapy Market Outlook, By Dark Circles (2024-2032) ($MN)
  • Table 23 Global Carboxy Therapy Market Outlook, By Cardiovascular and Diabetic Applications (2024-2032) ($MN)
  • Table 24 Global Carboxy Therapy Market Outlook, By Regenerative Medicine (2024-2032) ($MN)
  • Table 25 Global Carboxy Therapy Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 26 Global Carboxy Therapy Market Outlook, By End User (2024-2032) ($MN)
  • Table 27 Global Carboxy Therapy Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 28 Global Carboxy Therapy Market Outlook, By Aesthetic Clinics (2024-2032) ($MN)
  • Table 29 Global Carboxy Therapy Market Outlook, By Medspas (2024-2032) ($MN)
  • Table 30 Global Carboxy Therapy Market Outlook, By Spas and Salons (2024-2032) ($MN)
  • Table 31 Global Carboxy Therapy Market Outlook, By Beauty Centers (2024-2032) ($MN)
  • Table 32 Global Carboxy Therapy Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.